Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cerilliant
Johnson and Johnson
Daiichi Sankyo
Moodys
Teva
Farmers Insurance
US Department of Justice
Merck
Queensland Health

Generated: October 17, 2017

DrugPatentWatch Database Preview

Shire Llc Company Profile

« Back to Dashboard

What is the competitive landscape for SHIRE LLC, and when can generic versions of SHIRE LLC drugs launch?

SHIRE LLC has four approved drugs.

There are three US patents protecting SHIRE LLC drugs on SHIRE LLC drugs in the past three years.

There are ninety-nine patent family members on SHIRE LLC drugs in thirty-five countries and three supplementary protection certificates in two countries.

Summary for Applicant: Shire Llc

International Patents:99
US Patents:3
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-002Oct 26, 2004ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-003Mar 20, 2002DISCNYesNo► Subscribe► Subscribe► Subscribe
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-002Sep 6, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-004Nov 23, 2005ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Shire Llc
SALURON
hydroflumethiazide
TABLET;ORAL011949-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-004Nov 23, 2005ABRXYesYes► Subscribe► Subscribe ► Subscribe
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-002Oct 26, 2004ABRXYesNo► Subscribe► Subscribe ► Subscribe
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-001Sep 6, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-001Oct 26, 2004DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Shire Llc
FOSRENOL
lanthanum carbonate
TABLET, CHEWABLE;ORAL021468-003Nov 23, 2005ABRXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SHIRE LLC drugs

Drugname Dosage Strength Tradename Submissiondate
lanthanum carbonate
Oral Powder750 mg and 1000 mg
FOSRENOL
11/25/2015
lanthanum carbonate
Chewable Tablet500 mg, 750 mg and 1000 mg
FOSRENOL
10/27/2008

International Patent Family for Shire Llc Drugs

Country Document Number Estimated Expiration
Cyprus1110241► Subscribe
Iceland8353► Subscribe
Eurasian Patent Organization200801275► Subscribe
Czech Republic293494► Subscribe
HungaryE024906► Subscribe
Brazil9607926► Subscribe
World Intellectual Property Organization (WIPO)9630029► Subscribe
Turkey9701030► Subscribe
Spain2343354► Subscribe
South Africa200602213► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Shire Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2008005,C0817639Lithuania► SubscribePRODUCT NAME: LANTANO KARBONATO HIDRATAS; NAT. REGISTRATION NO/DATE: LT/1/07/0776/001-021 20071003; FIRST REGISTRATION: 17192, 2004-03-19 ; 18466, 2004-03-19; 21073, 2004-10-19; 21074 20041029
2008005Lithuania► SubscribePRODCUT NAME: LANTANO KARBONATO HIDRATAS; NAT. REG. DATE/NO: LT/1/07/0776/001-021; FIRST REG. DATE: 20040319
C/GB06/036United Kingdom► SubscribeSPC/GB06/036: 20061027
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Julphar
Covington
US Department of Justice
Citi
US Army
McKinsey
Johnson and Johnson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot